|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/517 | |
| C07D 239/70 | |||
| A61K 31/165 | |||
| A61K 31/4402 | |||
| A61P 35/00 | |||
| A61K 45/06 | |||
| A61K 31/166 | |||
| A61K 31/4523 |
| (11) | Number of the document | 2694073 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12764894.7 |
| Date of filing the European patent application | 2012-03-30 | |
| (97) | Date of publication of the European application | 2014-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/031716 |
| Date | 2012-03-30 |
| (87) | Number | WO 2012/135779 |
| Date | 2012-10-04 |
| (30) | Number | Date | Country code |
| 201161471038 P | 2011-04-01 | US |
| (72) |
LEE, Brian, US
LIN, Kui, US
NANNINI, Michelle, US
PUNNOOSE, Elizabeth, US
SAMPATH, Deepak, US
|
| (73) |
Genentech, Inc.,
One DNA Way, South San Francisco, CA 94080-4990,
US
|
| (54) | COMBINATIONS OF AKT AND MEK INHIBITORS FOR TREATING CANCER |
| COMBINATIONS OF AKT AND MEK INHIBITORS FOR TREATING CANCER |